Correlation Between Sartorius Stedim and Theradiag

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sartorius Stedim and Theradiag at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sartorius Stedim and Theradiag into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sartorius Stedim Biotech and Theradiag SA, you can compare the effects of market volatilities on Sartorius Stedim and Theradiag and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sartorius Stedim with a short position of Theradiag. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sartorius Stedim and Theradiag.

Diversification Opportunities for Sartorius Stedim and Theradiag

0.34
  Correlation Coefficient

Weak diversification

The 3 months correlation between Sartorius and Theradiag is 0.34. Overlapping area represents the amount of risk that can be diversified away by holding Sartorius Stedim Biotech and Theradiag SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Theradiag SA and Sartorius Stedim is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sartorius Stedim Biotech are associated (or correlated) with Theradiag. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Theradiag SA has no effect on the direction of Sartorius Stedim i.e., Sartorius Stedim and Theradiag go up and down completely randomly.

Pair Corralation between Sartorius Stedim and Theradiag

Assuming the 90 days trading horizon Sartorius Stedim Biotech is expected to generate 0.81 times more return on investment than Theradiag. However, Sartorius Stedim Biotech is 1.23 times less risky than Theradiag. It trades about -0.01 of its potential returns per unit of risk. Theradiag SA is currently generating about -0.03 per unit of risk. If you would invest  22,978  in Sartorius Stedim Biotech on August 28, 2024 and sell it today you would lose (5,138) from holding Sartorius Stedim Biotech or give up 22.36% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy99.72%
ValuesDaily Returns

Sartorius Stedim Biotech  vs.  Theradiag SA

 Performance 
       Timeline  
Sartorius Stedim Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sartorius Stedim Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong primary indicators, Sartorius Stedim is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Theradiag SA 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Theradiag SA are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Theradiag reported solid returns over the last few months and may actually be approaching a breakup point.

Sartorius Stedim and Theradiag Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sartorius Stedim and Theradiag

The main advantage of trading using opposite Sartorius Stedim and Theradiag positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sartorius Stedim position performs unexpectedly, Theradiag can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Theradiag will offset losses from the drop in Theradiag's long position.
The idea behind Sartorius Stedim Biotech and Theradiag SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Bonds Directory
Find actively traded corporate debentures issued by US companies
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance